Triamcinolone

DRUG INFORMATION

  ADULT
    - The initial dose of triamcinolone acetonide injectable suspension may vary from
      2.5 mg to 100 mg per day depending on the specific disease entity being treated
      (see Dosage section below).
      Source: US FDA label for triamcinolone (Triamcinolone Acetonide), section 'dosage
      and administration', retrieved 2026-08-29
    - Dosage SYSTEMIC The suggested initial dose is 60 mg, injected deeply into the
      gluteal muscle .
      Source: US FDA label for triamcinolone (Triamcinolone Acetonide), section 'dosage
      and administration', retrieved 2026-08-29
    - However, some patients may be well controlled on doses as low as 20 mg or less.
      Source: US FDA label for triamcinolone (Triamcinolone Acetonide), section 'dosage
      and administration', retrieved 2026-08-29

  CHILD
    - General NOTE: CONTAINS BENZYL ALCOHOL (see PRECAUTIONS). The initial dose of
      triamcinolone acetonide injectable suspension may vary from 2.5 mg to 100 mg per
      day depending on the specific disease entity being treated (see Dosage section
      below). However, in certain overwhelming, acute, life-threatening situations,
      administration in dosages exceeding the usual dosages may be justified and may be
      in multiples of the oral dosages.
      Source: US FDA label for triamcinolone (Triamcinolone Acetonide), section 'dosage
      and administration', retrieved 2026-08-29
    - The range of initial doses is 0.11 mg/kg/day to 1.6 mg/kg/day in 3 or 4 divided
      doses (3.2 mg/m 2 bsa/day to 48 mg/m 2 bsa/day).
      Source: US FDA label for triamcinolone (Triamcinolone Acetonide), section 'dosage
      and administration', retrieved 2026-08-29

  RENAL IMPAIRMENT
    - No kidney-impairment dose in this label. Not a statement that none is needed.
      Source: Read and found silent: the US FDA label for triamcinolone (Triamcinolone
      Acetonide), retrieved 2026-08-29

  HEPATIC IMPAIRMENT
    - No liver-impairment dose in this label. Not a statement that none is needed.
      Source: Read and found silent: the US FDA label for triamcinolone (Triamcinolone
      Acetonide), retrieved 2026-08-29

  PREGNANCY
    - Neuro-Psychiatric Although controlled clinical trials have shown corticosteroids
      to be effective in speeding the resolution of acute exacerbations of multiple
      sclerosis, they do not show that they affect the ultimate outcome or natural
      history of the disease.
      Source: US FDA label for triamcinolone (Triamcinolone Acetonide), section
      'pregnancy', retrieved 2026-08-29
    - The studies do show that relatively high doses of corticosteroids are necessary to
      demonstrate a significant effect.
      Source: US FDA label for triamcinolone (Triamcinolone Acetonide), section
      'pregnancy', retrieved 2026-08-29
    - An acute myopathy has been observed with the use of high doses of corticosteroids,
      most often occurring in patients with disorders of neuromuscular transmission
      (e.g., myasthenia gravis), or in patients receiving concomitant therapy with
      neuromuscular blocking drugs ( e.g., pancuronium).
      Source: US FDA label for triamcinolone (Triamcinolone Acetonide), section
      'pregnancy', retrieved 2026-08-29

  BREASTFEEDING
    - Information for Patients Patients should be warned not to discontinue the use of
      corticosteroids abruptly or without medical supervision, to advise any medical
      attendants that they are taking corticosteroids, and to seek medical advice at
      once should they develop fever or other signs of infection.
      Source: US FDA label for triamcinolone (Triamcinolone Acetonide), section 'nursing
      mothers', retrieved 2026-08-29
    - Persons who are on corticosteroids should be warned to avoid exposure to chicken
      pox or measles.
      Source: US FDA label for triamcinolone (Triamcinolone Acetonide), section 'nursing
      mothers', retrieved 2026-08-29
    - Patients should also be advised that if they are exposed, medical advice should be
      sought without delay.
      Source: US FDA label for triamcinolone (Triamcinolone Acetonide), section 'nursing
      mothers', retrieved 2026-08-29